文献速递心脑血管急症

急性ST段抬高型心肌梗死患者早期再灌注策略选择与预后分析:基于河北省49家医院数据

[Early reperfusion strategy selection and prognosis analysis in patients with acute ST segment elevation myocardial infarction: based on the data of 49 hospitals in Hebei Province].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论STEMI发病12小时内应尽早再灌注;PPCI较静脉溶栓血管开通率更高、院内死亡率更低,但1年及3年死亡率无显著差异。

该研究收集河北省49家医院2016年1月至12月急性心肌梗死患者治疗数据及3年随访结果,纳入发病12小时内接受静脉溶栓(ITT)或直接经皮冠状动脉介入(PPCI)的STEMI患者,比较两组基线、首次诊断至再灌注开始时间(ITT为FMC2N,PPCI为FMC2B)、血管开通率、院内死亡率、1年及3年死亡率。共纳入1371例(ITT组300例,PPCI组1071例),实际随访1055例(随访率79.4%)。PPCI组血管开通率高于ITT组[95.5%(1023/1071)vs. 88.3%(265/300),P<0.01],院内死亡率低于ITT组[2.1%(22/1071)vs. 6.7%(20/300),P<0.01],但1年及3年死亡率无显著差异。FMC2N>30分钟组血管开通率最低、院内死亡率最高。

要点

  • 共纳入1371例STEMI患者(ITT组300例,PPCI组1071例),实际随访1055例,随访率79.4%。
  • PPCI组血管开通率95.5%(1023/1071)高于ITT组88.3%(265/300),P<0.01。
  • PPCI组院内死亡率2.1%(22/1071)低于ITT组6.7%(20/300),P<0.01。
  • 1年死亡率[5.3%(45/850)vs. 4.4%(9/205)]及3年死亡率[9.5%(81/850)vs. 9.3%(19/205)]两组无显著差异(均P>0.05)。
  • FMC2N>30分钟组血管开通率最低[88.0%(220/250)]、院内死亡率最高[7.6%(19/250)]。

适用人群与场景

  • 河北省49家医院2016年1月至12月急性心肌梗死患者中,发病12小时内接受静脉溶栓(ITT)或直接经皮冠状动脉介入(PPCI)的STEMI患者。

处置流程与药物剂量

  • 对发病12小时内的STEMI患者,应尽快进行再灌注治疗(作者结论)。
  • 静脉溶栓患者记录首次诊断至溶栓开始时间(FMC2N);PPCI患者记录首次诊断至球囊扩张时间(FMC2B)。

研究设计与关键结果

  • 研究类型为基于49家医院治疗数据及3年随访结果的对比分析;共纳入1371例STEMI患者,ITT组300例,PPCI组1071例;实际随访1055例(ITT组205例,PPCI组850例),随访率79.4%。
  • 两组年龄、性别及既往史无显著差异。
  • 首次诊断至再灌注开始时间ITT组短于PPCI组[分钟:63(38,95)vs. 95(60,150),U=-9.286,P=0.000],但显著长于指南标准。
  • PPCI组血管开通率高于ITT组[95.5%(1023/1071)vs. 88.3%(265/300),P<0.01],院内死亡率低于ITT组[2.1%(22/1071)vs. 6.7%(20/300),P<0.01]。
  • 1年死亡率[5.3%(45/850)vs. 4.4%(9/205)]和3年死亡率[9.5%(81/850)vs. 9.3%(19/205)两组无显著差异(均P>0.05)。
  • 不同再灌注开始时间亚组中,FMC2N>30分钟组血管开通率最低[88.0%(220/250)]、院内死亡率最高[7.6%(19/250)]。
  • 两两比较:FMC2B≤120分钟组和FMC2B>120分钟组血管开通率均显著高于FMC2N>30分钟组[95.5%(654/685)、95.6%(369/386)vs. 88.0%(220/250),均P<0.008],院内死亡率均显著低于FMC2N>30分钟组[2.0%(14/685)、2.1%(8/386)vs. 7.6%(19/250),均P<0.008]。
  • 四组间1年死亡率(χ2=2.507,P=0.443)和3年死亡率(χ2=2.204,P=0.522)无显著差异。

证据类型、等级与局限

  • 证据类型:基于49家医院治疗数据及3年随访结果的对比分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对发病12小时内的STEMI患者,作者认为应尽快进行再灌注治疗。
  • 与静脉溶栓相比,PPCI显示更高的梗死相关动脉开通率和更低的院内死亡率,且对1年及3年死亡率无影响(作者结论)。
  • ITT组首次诊断至再灌注开始时间虽短于PPCI组,但显著长于指南标准。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the selection of strategies for early reperfusion therapy and its impact on prognosis in patients with acute ST segment elevation myocardial infarction (STEMI).

METHODS: The treatment data and 3-year follow-up results of acute myocardial infarction (AMI) patients in 49 hospitals in Hebei Province from January to December 2016 were collected. Patients with STEMI who received either intravenous thrombolytic therapy (ITT) or primary percutaneous coronary intervention (PPCI) within 12 hours of onset were enrolled. Baseline data, the time from the first diagnosis to the start of reperfusion (FMC2N for ITT patients and FMC2B for PPCI patients), vascular recanalization rate, in-hospital mortality, 1-year mortality, and 3-year mortality were compared between ITT and PPCI groups. The efficacy and prognosis of ITT and PPCI at different starting time of reperfusion (FMC2N ≤ 30 minutes, FMC2N > 30 minutes, FMC2B ≤ 120 minutes, FMC2B > 120 minutes) were analyzed.

RESULTS: A total of 1 371 STEMI patients treated with ITT or PPCI were selected, including 300 patients in the ITT group and 1 071 patients in the PPCI group. 1 055 patients were actually followed up (205 patients in the ITT group and 850 patients in the PPCI group), with a rate of 79.4%. There were no significant differences in age, gender, and previous history between the two groups. The time from the first diagnosis to the start of reperfusion in the ITT group was shorter than that in the PPCI group [minutes: 63 (38, 95) vs. 95 (60, 150), U = -9.286, P = 0.000], but was significantly longer than the guideline standard. Compared with the ITT group, the vascular recanalization rate in the PPCI group was higher [95.5% (1 023/1 071) vs. 88.3% (265/300), P < 0.01], and in-hospital mortality was lower [2.1% (22/1 071) vs. 6.7% (20/300), P < 0.01], but there were no significant differences in the 1-year mortality and 3-year mortality [5.3% (45/850) vs. 4.4% (9/205), 9.5% (81/850) vs. 9.3% (19/205), both P > 0.05]. Between ITT group and PPCI group with different reperfusion starting time, the FMC2N > 30 minutes group had the lowest vascular recanalization rate and the highest in-hospital mortality. Pairwise comparison showed that the vascular recanalization rate of the FMC2B ≤ 120 minutes group and the FMC2B > 120 minutes group were significantly higher than those of the FMC2N > 30 minutes group [95.5% (654/685), 95.6% (369/386) vs. 88.0% (220/250), both P < 0.008], the in-hospital mortality was significantly lower than that of the FMC2N > 30 minutes group [2.0% (14/685), 2.1% (8/386) vs. 7.6% (19/250), both P < 0.008]. There was no significant difference in 1-year mortality (χ2 = 2.507, P = 0.443) and 3-year mortality (χ2 = 2.204, P = 0.522) among the four groups.

CONCLUSIONS: For STEMI patients within 12 hours of onset, reperfusion therapy should be performed as soon as possible. PPCI showed higher infarct related artery opening rate and lower in-hospital mortality compared with ITT, and had no effect on 1-year and 3-year mortality.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Peng N, Xiao H, Dong Y, et al. [Early reperfusion strategy selection and prognosis analysis in patients with acute ST segment elevation myocardial infarction: based on the data of 49 hospitals in Hebei Province]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34112296. doi:10.3760/cma.j.cn121430-20210207-00228

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。